D. Quietzsch

Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Gemcitabine Alone in Advanced Pancreatic Cancer

Volker Heinemann, D. Quietzsch, Frank Gieseler et al. · Journal of Clinical Oncology · 2006 · 682 citations

A phase II study of paclitaxel, weekly, 24-hour continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer

Christian Kollmannsberger, D. Quietzsch, Christian Haag et al. · British Journal of Cancer · 2000 · 114 citations · Full text

Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial

Stefan Boeck, K. Weigang-Köhler, Martin Fuchs et al. · Annals of Oncology · 2007 · 68 citations · Full text

Surgical Oncology, Pancreatic Cancer, Gemcitabine Failure +8

Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer

Ludwig Fischer von Weikersthal, Andreas Schalhorn, Martina Stauch et al. · European Journal of Cancer · 2010 · 59 citations

Oncology, Medicine, Phase Iii Trial +8

Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer

Friedemann Honecker, Christian Kollmannsberger, D. Quietzsch et al. · Anti-Cancer Drugs · 2002 · 52 citations